Finance

Lists
Why is BVS down 2,38%?
Dive Deeper
BVS:NASDAQ
Bioventus Inc
13,13 $
-2,38%
(-0,32) 1D
2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BVS...
Open
13,52 $
High
13,52 $
Low
13,02 $
Mkt. cap
1,10 մլրդ
Avg. vol.
515,50 հզր
Volume
0,00
52-wk high
15,89 $
52-wk low
6,37 $
Beta
0,64
Shares outstanding
68,30 մլն
No. of employees
950
Open
13,52 $
High
13,52 $
Low
13,02 $
Mkt. cap
1,10 մլրդ
Avg. vol.
515,50 հզր
Volume
0,00
52-wk high
15,89 $
52-wk low
6,37 $
Beta
0,64
Shares outstanding
68,30 մլն
No. of employees
950
News stories
From web sources and news partners
About Bioventus Inc
CEO-
Employees950
Founded2011
Headquarters-
Sector-
Websitebioventus.com
Analyst ratings
Based on 4 analysts giving stock ratings to BVS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BVS in the last 3 months.
Highest
Current 13,13 $
19,00 $ (+44,71%)
Average
17,50 $ (+33,28%)
Lowest
15,00 $ (+14,24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
15,00 $
+14,2%
08/17/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
19,00 $
+44,7%
08/17/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
19,00 $
+44,7%
08/17/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
18,00 $
+37,1%
08/06/2026
Michael Petusky
Barrington
Buy
Maintained
18,00 $
+37,1%
08/06/2026
Lawrence Solow
CJS Securities
Buy
Initiated
14,00 $
+6,6%
03/27/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,22 $ / 0,22 $
+0,92%beat
Revenue / Est. (USD)
153,21 մլն / 155,64 մլն
-1,56%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
138,65 մլն
157,90 մլն
132,09 մլն
153,21 մլն
Cost of goods sold
44,42 մլն
49,12 մլն
41,32 մլն
47,54 մլն
Cost of revenue
44,42 մլն
49,12 մլն
41,32 մլն
47,54 մլն
Research and development expenses
2,92 մլն
3,01 մլն
2,47 մլն
3,17 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
78,64 մլն
82,76 մլն
78,31 մլն
82,72 մլն
Operating expense
82,96 մլն
87,06 մլն
81,88 մլն
86,93 մլն
Total operating expenses
127,39 մլն
136,18 մլն
123,20 մլն
134,47 մլն
Operating income
11,26 մլն
21,72 մլն
8,89 մլն
18,73 մլն
Other non operating income
-79,00 հզր
-2,01 մլն
427,00 հզր
-
EBT including unusual items
4,67 մլն
14,14 մլն
4,52 մլն
15,31 մլն
EBT excluding unusual items
5,01 մլն
16,38 մլն
4,99 մլն
14,92 մլն
Income tax expense
664,00 հզր
-3,18 մլն
571,00 հզր
-20,90 մլն
Effective tax rate
14,22%
-22,45%
12,64%
-136,51%
Other operating expenses
-
-
-
-
Net income
3,16 մլն
14,76 մլն
3,11 մլն
33,44 մլն
Net profit margin
2,28%
9,34%
2,36%
21,83%
Earnings per share
0,15
0,24
0,15
0,22
Interest and investment income
-
-
-
-
Interest expense
-6,18 մլն
-5,31 մլն
-4,33 մլն
-4,07 մլն
Net interest expenses
-6,18 մլն
-5,31 մլն
-4,33 մլն
-4,07 մլն
Depreciation and amortization charges
1,40 մլն
1,30 մլն
1,11 մլն
1,04 մլն
EBITDA
22,67 մլն
27,05 մլն
20,09 մլն
29,68 մլն
Gain or loss from assets sale
-1,00 հզր
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps